EPIVIR

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug EPIVIR contains one active pharmaceutical ingredient (API):

1	Lamivudine UNII 2T8Q726O95 - LAMIVUDINE
	Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.
	Read more about Lamivudine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EPIVIR Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AF05	Lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510602601117317, 510602602131313
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00728931, 02245585, 02699607, 03864149, 03882526, 04050845, 04764958, 05746141, 05907360, 07518467, 11220667
EE	Ravimiamet	1025873, 1209697, 1209709
ES	Centro de información online de medicamentos de la AEMPS	96015001, 96015002, 96015003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	101927, 101938, 101950
FR	Base de données publique des médicaments	62715513, 64777862, 68036070
GB	Medicines & Healthcare Products Regulatory Agency	26726, 26740, 26744
IL	מִשְׂרַד הַבְּרִיאוּת	3291, 3382, 4776
JP	医薬品医療機器総合機構	6250006F1031, 6250006F2020
LT	Valstybinė vaistų kontrolės tarnyba	1010269, 1010270, 1028025, 1028026, 1028027
NL	Z-Index G-Standaard	14017385
NL	Z-Index G-Standaard, PRK	44695, 44709, 59218
PL	Rejestru Produktów Leczniczych	100017240, 100087400, 100309645
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65301002, W65301003, W65302002, W65302003, W65303002
SG	Health Sciences Authority	09134P, 09135P
TN	Direction de la Pharmacie et du Médicament	14293021H, 23013021
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522092666, 8699522592654
US	FDA, National Drug Code	0173-0662, 0173-0663, 49702-203, 49702-204, 49702-205